HPM Partners »

Intra Cellular Therapies shares owned by HPM Partners

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by HPM Partners

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.7M 20k 131.92
2024-12-31 $3.2M 41k 76.24
2024-09-30 $3.2M 44k 73.17
2024-06-30 $1.9M 27k 68.49
2024-03-31 $2.4M 34k 69.20
2023-12-31 $266k 3.7k 71.62

More positions owned by HPM Partners

Vanguard Index Fds Etf (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corp Stock (MSFT)
iShares S&P 500 Index (IVV)
Spdr S&p 500 Etf (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Etf (IEFA)
Amazon Stock (AMZN)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Alphabet Stock (GOOGL)
Alphabet Stock (GOOG)
Ishares Tr Etf (QUAL)
Meta Platforms Stock (META)

View all positions for HPM Partners

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies